Summary
Highlights
The video introduces autoimmune neuromuscular disorders where the body attacks itself, specifically discussing Myasthenia Gravis (descending paralysis), Guillain-Barré Syndrome (ascending paralysis), and Multiple Sclerosis (demyelination). These conditions disrupt nerve-muscle communication, leading to weakness, fatigue, and mobility problems.
Myasthenia Gravis (MG) is an autoimmune disorder where antibodies block or destroy acetylcholine receptors at the neuromuscular junction, impairing nerve transmission and causing muscle fatigue and weakness. Symptoms worsen with activity and improve with rest, primarily affecting muscles used for repetitive movements like blinking, speaking, swallowing, and breathing, leading to drooping eyelids (ptosis), weak facial muscles, difficulty chewing (dysphagia), and slurred speech.
The Edrophonium (Tensilon) test is used for diagnosis; it temporarily blocks acetylcholinesterase, improving muscle strength. Atropine must be available due to the risk of bradycardia. Pyridostigmine, an anticholinesterase, increases available acetylcholine to improve symptoms. Nurses should prevent fatigue by encouraging rest and scheduling activities early. Protecting the airway is crucial due to weakened swallowing muscles. Medication should be administered 30 minutes before meals to improve swallowing and prevent aspiration. Diet should be soft or pureed.
Myasthenic crisis, caused by stress, infection, or undertreatment, results in severe muscle weakness, possibly leading to respiratory failure. IV immunoglobulins (IVIg) are administered. Cholinergic crisis, caused by overtreatment with anticholinesterase drugs, leads to excessive acetylcholine, presenting with muscle weakness, salivation, lacrimation, urination, diarrhea, GI upset, and emesis (SLUDGE). Atropine is used to treat cholinergic crisis by blocking acetylcholine receptors.
Guillain-Barré Syndrome (GBS) is an acute autoimmune attack on peripheral nerves, affecting cranial and spinal nerves. It is often triggered by trauma, vaccines, or infections (e.g., Campylobacter). GBS involves damage to the myelin sheath, impairing signal transmission and causing paralysis. Key assessment findings include ascending muscle weakness or paralysis, starting in the legs and spreading upwards, potentially affecting the diaphragm, and absent deep tendon reflexes (areflexia).
The primary nursing intervention for GBS is monitoring for respiratory distress and preparing for intubation due to the risk of respiratory muscle paralysis. IV immunoglobulins (IVIg) are given to decrease symptom severity. To prevent immobility complications, nurses perform DVT prophylaxis (sequential compression devices, anticoagulants), provide physical therapy to prevent contractures, and frequent repositioning to prevent skin breakdown. Recovery is gradual as antibodies clear, often aided by plasmapheresis to filter and remove attacking antibodies.